Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria. - Wikidata - awgldk - TriplyDB

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.

http://www.wikidata.org/entity/Q37077284

about

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs Mathematical Modelling to Guide Drug Development for Malaria Elimination Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants Artemisinin combination therapy: a good antimalarial, but is the dose right?Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.Characterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousness Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.

P2860

Q21032449-522CC5BB-3478-405A-BF45-E11AF5F2E136 Q26822489-0B10BAD4-1F66-4405-B83D-9B6009588ED5 Q26830528-266B97A2-66DE-42BE-9CAE-37B7F64A90DA Q27025529-B82B726F-AB98-4798-BF26-9E3DCDFB1EC9 Q28067367-3C750711-9E55-412A-BEC8-D80C4E526329 Q28535686-2CEE212B-F3B6-4CF2-877A-BAA2EE4C11ED Q28541598-E931AEBA-AF63-4BC4-A434-66967F001F4F Q28542034-0038E909-FC51-433C-AD1B-FF300B6326BA Q31153944-EE1A6468-AAF8-4188-AA49-E2125FEB7FF0 Q33612551-34B24134-25B6-4438-BF5B-FA5E93BE3D9C Q33622892-A5D5F6BC-BFAF-4F4E-B351-9C8CB2F876EC Q33678483-1A020EA5-8F3C-4FB9-BAFC-AC409C61FA49 Q34057403-4F271E1B-EFCA-4BC4-B422-51F9CE2B0E36 Q34116219-8F1FBE48-0CB2-4C03-BD1B-C011B79B7DF1 Q34299078-BDBAA23C-5317-49C5-A98B-C2180F6F4887 Q34299178-A5FF10FD-FB5A-4511-B6F2-D2EA0A5C4374 Q34503134-890DF774-B256-4E8C-9BD6-643A669BF876 Q34677891-A86CB060-215B-4EF3-AAA4-3DFA152F25F5 Q34953705-601823A4-7668-4F17-A12F-1D5280D93253 Q35055212-F65D8BE9-1C91-49FB-B1E1-D312DD780452 Q35069127-83D52C2C-8E9B-496C-812B-4CCFC41D9C22 Q35097323-39477AB8-C8C5-4469-BF26-D4425586EEDA Q35224221-69611379-14D0-4E2B-97BC-C6DB8A5408BE Q35580908-12CA6703-9B62-4103-9E19-11331D72D3AD Q35804683-CE7C7493-1A0E-401A-8289-8DC0B9F6AF13 Q35859839-44DF96B9-9E1A-4DCA-BA31-0068D30E4ACD Q35859844-D576901F-CC7F-440F-887B-BF4A90EEFD21 Q36018444-EBFA595B-9F00-4DAE-BA80-3A259C7B8B9F Q36075783-56E89E8C-E05F-4EF0-8CC9-8A6AC12C1F35 Q36088256-B9D9D4C5-0905-443D-9A64-1DF5AC79519A Q36092227-5ADC60BF-974C-461D-B2FD-4D707A14A552 Q36433138-CD76869F-116F-40F5-8433-D471782E0FAB Q36471679-A2BCEC31-9AF9-4AE9-87BD-E0C7BCA21684 Q36508726-3AC13FE7-D8C8-4981-838C-8681DEE9F23E Q36552289-92F8DDB2-A650-478C-BFEE-7FE3CDB2B24F Q36558387-2B03BB94-651D-44E3-A554-3B6346329C65 Q36689509-BEE39F4F-5399-43B9-96D0-F0F4A58184A2 Q36778732-3AB0B90F-EF33-4EE9-8E3C-4B4BEC49CC2E Q37038270-5AA29B2C-65E7-4227-A51B-BB670DA9AF14 Q37383670-942439EA-6BA5-469B-9902-63435024D2BA

P2860

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.

http://www.wikidata.org/entity/Q37077284

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics an ...... omplicated falciparum malaria.

@en

Population pharmacokinetics an ...... omplicated falciparum malaria.

@nl

type

label

Population pharmacokinetics an ...... omplicated falciparum malaria.

@en

Population pharmacokinetics an ...... omplicated falciparum malaria.

@nl

prefLabel

Population pharmacokinetics an ...... omplicated falciparum malaria.

@en

Population pharmacokinetics an ...... omplicated falciparum malaria.

@nl

P1433

Q37077284-576FBC62-3995-4EEA-8C38-38A35678AAC1

P1476

Q37077284-AB3C9AC7-4732-464A-A312-FBA545FA7FF4

P2093

Q37077284-0CF68285-1CDE-4836-824D-69B90F66EAFA

Q37077284-12AB0B24-96B3-4288-B06F-46C2FD6A7875

Q37077284-2C82DF4E-7C4C-48B4-B808-0ADF5AE8E49B

Q37077284-A7F8CD0A-8C0A-415A-B2F3-301646B7409D

Q37077284-B2F8A8E4-AFD1-4273-B74F-A73A43E9C47B

Q37077284-B4865B69-260D-4F20-AADB-B1382A6480D1

Q37077284-DB7A19CF-D1F1-4DB8-A542-2653E79EB21C

Q37077284-DDA608E9-52BD-4CDD-9923-D6AAA4A5D0CD

Q37077284-DF5379F9-20DA-4AC3-85BC-598F08EB8E25

Q37077284-E47B56F4-180B-4933-B540-FEAA318721B4

P2860

Q37077284-03FB298F-B459-4A0C-80EC-3E4AFABE2C9E

Q37077284-04FE584C-C9B0-4B74-AB6A-A36F81954427

Q37077284-07EDB38B-138D-4FA0-8E72-538334E36FD8

Q37077284-1766BD42-E90C-4E72-8DA5-E4A231F461E3

Q37077284-19448D24-1219-44D9-9759-CF37EB2D48CD

Q37077284-2AF166B8-8EBC-4385-8F94-BDD1B1E10830

Q37077284-2D9B3176-900F-47DC-B8E4-A0C54AA8562F

Q37077284-3929D5C4-F075-45A5-89D8-A59E84410B73

Q37077284-3D93694C-BFB3-4269-BA59-1B0F634DC2E3

Q37077284-4659FB9B-F82D-4108-8BE6-00D106404E97

P304

Q37077284-E3950C02-FA8A-40D1-A9F9-BED728610EE7

P31

Q37077284-B01633B9-A221-4439-A918-C4885AC79613

P356

Q37077284-1EC13C72-878E-4E39-AC05-57A5FC2B9F64

P407

Q37077284-E4C618A1-9A2E-4962-A3CD-545BEA98018A

P433

Q37077284-838CBE5D-C13A-4327-B620-F08544932D39

P478

Q37077284-E6AEAA86-90B7-4CD7-AB38-508E2D049F84

P50

Q37077284-96153C0E-9E18-4359-8133-BA5EAEFAD8F2

Q37077284-BD0A59E5-5EA2-4F83-9EC0-A67D0AEAF936

Q37077284-FEC0A025-6C55-4EBC-890B-9F36EF8C028E

P577

Q37077284-E8D355D7-158D-4E81-AD0F-9022DD6EC342

P698

Q37077284-3833E073-98ED-4773-89FC-262D8C431347

P921

Q37077284-29814322-ACCF-4A53-A0CF-2564D493B654

Q37077284-D1390455-3EE7-42F5-AEDE-0D0FE44E9483

P932

Q37077284-423305A8-DDEC-47B5-ABA9-E574D708804E

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Population pharmacokinetics an ...... omplicated falciparum malaria.

@en

P2093

F A Somé

http://www.w3.org/2001/XMLSchema#string

I Zongo

http://www.w3.org/2001/XMLSchema#string

J Tarning

http://www.w3.org/2001/XMLSchema#string

J-B Ouedraogo

http://www.w3.org/2001/XMLSchema#string

N Jongrak

http://www.w3.org/2001/XMLSchema#string

N Lindegardh

http://www.w3.org/2001/XMLSchema#string

N Rouamba

http://www.w3.org/2001/XMLSchema#string

P J Rosenthal

http://www.w3.org/2001/XMLSchema#string

S Parikh

http://www.w3.org/2001/XMLSchema#string

W Hanpithakpong

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.

Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.

Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Effects of a high-fat meal on the relative oral bioavailability of piperaquine

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.

P304

497-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2011.254

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Nicholas P J Day

P577

2012-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22258469

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3736305

http://www.w3.org/2001/XMLSchema#string